An observational study in Chronic Total Occlusion of Coronary Artery and Chronic Total Occlusion, sponsored by University Hospital Ulm. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-02.
Sponsored by University Hospital Ulm · Observational
The aim of the proposed project is to provide the long-term results after a recanalization attempt of chronically occluded coronary arteries.
To investigate recanalization attempt of chronically occluded coronary arteries at the Ulm University Hospital. As shown, it is known that successful recanalization of a chronic occlusion is associated with a lower event rate (reduced mortality and the need for operative myocardial revascularization) compared to unsuccessful recanalization (drug therapy). The standard in the therapy of successfully recanalized chronic occlusions is the use of drug-releasing vascular supports.
University Hospital Ulm is the lead sponsor of 10 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with CTO
Coronary intervention in chronic coronary artery occlusion
Occlusion > 3 months
Indication for PTCA or recanalization according to guidlines
such as:
Symptoms of the patient
Evidence of myocardial ischemia (stress ECG, scintigraphic
Methods, magnetic resonance imaging, stress echocardiography)
pathological intracoronary flow reserve, prognostic
Exclusion Criteria:
Acetylsalicylic acid plus clopidogrel for at least 3 months such as e.g.
with florid gastrointestinal ulcer disease,
History of hemorrhagic stroke
or urgent non-postponable surgical intervention.
Basic disease with a life expectancy of less than 12 months (here as a rule
no indication for PTCA or reopening available)
Procedure: PCI - percutaneous coronary intervention
Procedure: PCI - percutaneous coronary intervention
percutaneous coronary intervention
Also known as: drug eluting stents, Scaffolds, drug eluting ballons
MACE
major adverse cardiac event
Time frame: 1 year
TLR
target lesion revascularization
Time frame: 1 year
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Ulm